Clinical Trial: Levodopa for the Treatment of Residual Amblyopia

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Randomized Trial of Levodopa as Treatment for Residual Amblyopia (ATS 17)

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of oral levodopa and patching versus oral placebo and patching as treatment for residual amblyopia in children 7 to <13 years old with visual acuity of 20/50 to 20/400 in the amblyopic eye.